| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6828524 | Schizophrenia Research | 2009 | 8 Pages |
Abstract
Given the elevated risk of cardiovascular morbidity among individuals with schizophrenia, our findings add to the importance of screening and intervention programs for metabolic disorders and known cardiovascular risk factors among patients with schizophrenia.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Russell C. Callaghan, Matthew D. Boire, Roberto G. Lazo, Kwame McKenzie, Tony Cohn,